MENU
JPMA
  • Access
  • Japanese
  • About JPMA

    About JPMA Top

    • Message from the President
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • About Pharmaceuticals

    About Pharmaceuticals Top

    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee

    Information from the Committee Top

    • Code Compliance Committee
    • Pharmaceutical Industrial Policy Committee
    • Distribution Improvement Committee
    • Drug Evaluation Committee
    • Quality & Technology Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • R&D Committee
    • International Affairs Committee
    • Public Affairs Committee
    • Patient Cooperation Committee
    • ICH Project
    • APAC Project
    • Consumer Consultation Review Committee
    • Environmental Issue Committee
  • Newsletter
  • News Room

    Newsroom Top

    • News Releases and Announcements
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video content and advertisements
  • The Office of Pharmaceutical Industry Research
Close
JPMA

Return to Site Top

  • For Patients and the Public (About Pharmaceuticals)
    For Patients and the Public (Pharmaceuticals) Top
    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee
    Information from the Committee Top
    • Code Compliance Committee
    • Pharmaceutical Industrial Policy Committee
    • Distribution Improvement Committee
    • Drug Evaluation Committee
    • Quality & Technology Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • R&D Committee
    • International Affairs Committee
    • Public Affairs Committee
    • Patient Cooperation Committee
    • ICH Project
    • APAC Project
    • Consumer Consultation Review Committee
    • Environmental Issue Committee
  • About JPMA
    About JPMA Top
    • Message from the President
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • Policies and Activities
    Policies and Activities Top
    • Business Policy, Business Plan, and Implementation Plan
    • Committee Activities
    • Convention on Biological Diversity
  • Voluntary Standards
    Voluntary Standards Top
    • Charter of Conduct
    • JPMA Code of Practice
    • Transparency Guideline for the Relation between Corporate Activities and Medical Institutions
    • Transparency Guideline for Relationships between Corporate Activities and Patient Groups
    • Guidelines for the Preparation of Product Information Summaries for Ethical Drugs (Abbreviated name: Preparation Guidelines)
    • Clinical Research
    • Basic Philosophy and Action Guidelines on Biodiversity
    • Guidelines Concerning Appropriate Competition in Japan Pharmaceutical Manufacturers Association Meetings
    • Guidelines for the Promotion of Pharmaceutical Industry in Japan
  • News Room
    Newsroom Top
    • News Releases and Announcements
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video content and advertisements
  • The Office of Pharmaceutical Industry Research  Page will open in a new window.
  • Social Media Policy
  • Website Terms of Use
  • Access
  • Japanese
  • Top
  • Information from the Committee
  • Public Affairs Committee
  • PR and Communication Activities

PR and Communication Activities

Information on current PR measures and communication activities, as well as contents of past communication plans.

  • 2025

    With the aim of fostering future medical human resources and educating young people about the industry, we sponsored the "Senden Kaigi Award for Junior and Senior High School Students" for the year 2025. In addition, young employees from JPMA member companies spoke at a career event for students and companies aimed at gaining corporate recognition and mutual exchange with college freshmen and sophomores nationwide.

  • FY2024

    We held events for the kids demographic starting with the Science Museum's "Drug Room-Xurium" and developed videos to help them understand the industry and occupations related to the pharmaceutical industry using content operated by Mynavi Corporation.

  • FY2023

    We developed a PR plan to promote understanding of the pharmaceutical industry to a large number of stakeholders by holding educational events and distributing programs.

  • FY2022

    We developed a PR plan to communicate the potential and current challenges of the pharmaceutical industry, the risk of drug lag/loss and the need for drug discovery innovation by a number of experts from various media.

  • Fiscal 2021

    We developed three different publicity measures utilizing digital tools, SNS, and events combining real and online activities.

Share this page

  • Tweet
  • Share this page

TOP

Site Search

  • Top
  • Information from the Committee
  • Public Affairs Committee
  • PR and Communication Activities
  • JPMA PR and Communication Activities
  • Pharmaceutical Research Institute
  • List of Non-Financial Information Disclosure by Member Companies
  • STOP AMR
  • About JPMA
  • Policies and Activities
  • Voluntary Standards
  • Global Health
  • News Room
  • For Patients and the Public (About Pharmaceuticals)
  • Clinical Trials Information
  • Information from the Committee
  • JapanesePage will open in a new window.
  • x
  •  facebook
  •  youtube
  • Site Map
  • Website Terms of Use
  • Privacy Policy
  • Social Media Policy
  • Linking Policy
  • Accessibility Policy
  • PRAISE-NET Login

© Japan Pharmaceutical Manufacturers
Association(JPMA).

Notification

This website uses automatic translation.
The translated content may not always be fully consistent with the original Japanese content.